NCT07317154 Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients Status RECRUITING Phase PHASE1
NCT06412172 The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) Status RECRUITING Phase N/A
NCT04724980 Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03465280 Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) Status UNKNOWN Phase N/A
NCT02859454 Avelumab for People With Recurrent Respiratory Papillomatosis Status COMPLETED Phase PHASE2
NCT02854761 Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) Status UNKNOWN Phase PHASE1
NCT02632344 Pembrolizumab for HPV-associated Recurrent Respiratory Papilloma Patients Status COMPLETED Phase PHASE2
NCT02592902 Recurrent Respiratory Papillomatosis and Extraesophageal Reflux Status COMPLETED Phase NA
NCT02555800 Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis Status UNKNOWN Phase PHASE2
NCT02217358 Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions Status COMPLETED Phase NA
NCT01995721 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children Status UNKNOWN Phase PHASE3
NCT01793168 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Status RECRUITING Phase N/A
NCT01058317 Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis Status WITHDRAWN Phase PHASE2/PHASE3
NCT01020747 Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP) Status COMPLETED Phase PHASE1
NCT00829608 Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis Status WITHDRAWN Phase EARLY_PHASE1
NCT00747461 Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") Status TERMINATED Phase PHASE4
NCT00571701 Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis Status COMPLETED Phase PHASE2